<DOC>
	<DOCNO>NCT01620333</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate pharmacokinetics biphasic insulin aspart 50 ( NN-X14Mix50 ) biphasic insulin aspart 70 ( NN-X14Mix70 ) Japanese healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetics Biphasic Insulin Aspart 50 70 Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Healthy Japanese Body Mass Index ( BMI ) 1927 kg/m^2 ( inclusive ) Fasting blood glucose 3.86 mmol/L ( 68.4108.0 mg/dL ) ( inclusive Considered generally healthy upon completion medical history physical examination , judge Investigator SubInvestigator Clinically significant abnormal haematology biochemistry screen test , judge Investigator SubInvestigator ( ) Any serious systemic infectious disease occur 4 week prior screen , judge Investigator SubInvestigator Any intercurrent illness may affect blood glucose , judge Investigator SubInvestigator Hepatitis B C , HIV ( human immunodeficiency virus ) Use prescription drug within 2 week precede screen Use nonprescription drug , except routine vitamin drug may Blood donation 1150 mL within last 12 month Subjects first degree relative diabetes mellitus History presence diabetes History presence cancer clinically significant cardiac , respiratory , metabolic , renal , hepatic , gastrointestinal , endocrinological , dermatological , venereal , haematologic , neurologic , psychiatric disease disorder Previous history serious allergy anaphylactic reaction Subjects consume 28 unit alcohol per week significant history alcoholism drug/chemical abuse Subjects smoke 5 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>